These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 36482635)
1. Association between presence of Bacillus Calmette-Guerin vaccine scar and coronavirus disease 2019. Caliskaner Ozturk B; Vardaloglu I; Ongel Harbiyeli D; Gungordu N; Senkardesler G; Aliyeva N; Ismayilova A; Can G; Balkan II; Gemicioglu B; Borekci S Medicine (Baltimore); 2022 Dec; 101(48):e32185. PubMed ID: 36482635 [TBL] [Abstract][Full Text] [Related]
2. A case series of bacillus Calmette-Guérin scar reactivation after administration of both mRNA and viral vector COVID-19 vaccines. van Balveren L; van Puijenbroek EP; Davidson L; van Hunsel F Br J Clin Pharmacol; 2023 Jul; 89(7):2113-2121. PubMed ID: 36717367 [TBL] [Abstract][Full Text] [Related]
3. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19. Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464 [TBL] [Abstract][Full Text] [Related]
4. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial. Koekenbier EL; Fohse K; van de Maat JS; Oosterheert JJ; van Nieuwkoop C; Hoogerwerf JJ; Grobusch MP; van den Bosch MAAJ; van de Wijgert JHH; Netea MG; Rosendaal FR; Bonten MJM; Werkhoven CHHV; Clin Microbiol Infect; 2023 Jun; 29(6):781-788. PubMed ID: 36736662 [TBL] [Abstract][Full Text] [Related]
5. 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19. Lobo N; Brooks NA; Zlotta AR; Cirillo JD; Boorjian S; Black PC; Meeks JJ; Bivalacqua TJ; Gontero P; Steinberg GD; McConkey D; Babjuk M; Alfred Witjes J; Kamat AM Nat Rev Urol; 2021 Oct; 18(10):611-622. PubMed ID: 34131332 [TBL] [Abstract][Full Text] [Related]
6. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142 [TBL] [Abstract][Full Text] [Related]
7. The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19. Wang J; Zhang Q; Wang H; Gong W Front Biosci (Landmark Ed); 2022 May; 27(5):157. PubMed ID: 35638424 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial. Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739 [TBL] [Abstract][Full Text] [Related]
9. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature. Ręka G; Korzeniowska A; Piecewicz-Szczęsna H Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218 [TBL] [Abstract][Full Text] [Related]
10. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Charoenlap S; Piromsopa K; Charoenlap C Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943 [TBL] [Abstract][Full Text] [Related]
11. Are BCG-induced non-specific effects adequate to provide protection against COVID-19? Vashishtha VM Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516 [TBL] [Abstract][Full Text] [Related]
13. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170 [TBL] [Abstract][Full Text] [Related]
14. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration. Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336 [TBL] [Abstract][Full Text] [Related]
15. Is There a Rationale for Using Maheshwari N; Jain A Viral Immunol; 2021 Jun; 34(5):300-306. PubMed ID: 32857679 [TBL] [Abstract][Full Text] [Related]
17. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity. Parmar K; Siddiqui A; Nugent K Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721 [TBL] [Abstract][Full Text] [Related]
18. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019. Kumari P; Gupta UD; Bhagyawant SS Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459 [TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guérin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study. Weng CH; Saal A; Butt WW; Bica N; Fisher JQ; Tao J; Chan PA Epidemiol Infect; 2020 Jul; 148():e140. PubMed ID: 32641191 [TBL] [Abstract][Full Text] [Related]
20. Previous BCG vaccination is associated with less severe clinical progression of COVID-19. Pereira SM; Barreto FR; de Souza RA; de Souza Teles Santos CA; Pereira M; da Paixão ES; de Jesus Lima CCO; da Natividade MS; Lindoso AABP; Fernandes EG; Junior EBC; Pescarini JM; de Andrade KVF; de Souza FM; de Britto EA; Nunes C; Ichihara MY; Dalcolmo M; Trajman A; Barral-Netto M; Abubakar I; Barreto ML; de Alencar Ximenes RA; Rodrigues LC BMC Med; 2023 Apr; 21(1):145. PubMed ID: 37055776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]